News|Videos|July 14, 2025
Your Opinion About Long-Acting PrEP: Fortune Effiong, Nigeria | IAS 2025
Author(s)Peter Wehrwein, Managing Editor
Advertisement
We asked people attending the International AIDS Society meeting in Kigali, Rwanda, their opinion about long-acting injectable HIV preexposure prophylaxis and what it could mean for HIV prevention. Fortune Effiong, a researcher at the University of Calabar Teaching Hospital in Nigeria, shared his views about the potential of self-injectable versions of PrEP.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
California PBM Law is a Starting Point for Real Transparency
2
Sponsored: The Teva Biosimilars Trend Report
3
Topical Ruxolitinib Cream Rapidly Repigments Vitiligo Lesions, Study Finds
4
WHO Global Report on Antimicrobial Resistance Sheds Light on Growing Threat
5